A new version of the diabetes drug glyburide may help prevent deadly brain swelling in patients with a devastating stroke.
During a stroke, fluid can build up in the brain when a clot blocks one of the large arteries of the brain. The fluid causes extreme swelling and brain tissue shifts that can be deadly. The only proven treatment is surgery to open the skull and relieve the swelling.
In a preliminary study, researchers injected the new drug in 10 patients at risk of the swelling. Two of the patients still developed the condition. Typically, about nine out of 10 similar stroke patients who don’t receive the drug develop brain swelling.
Researchers said more trials are needed to better understand the safety and value of the drug.
- International Stroke Conference – Basic Science News
- Learn more about the Effects of Stroke and Stroke Treatment.
- Learn to spot a stroke F.A.S.T.
Stories appearing on blog.heart.org under the "By American Heart Association News" byline are available for linking, quoting, excerpting and reprinting. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to the American Heart Association. Additional conditions may apply to the use of these stories in printed materials.
American Heart Association additional conditions for linking, quoting, excerpting, reprinting stories in print media
- A credit line of American Heart Association News must be prominently placed on the page in which the American Heart Association materials appear.
- The American Heart Association logo and service marks may only be used if they appear on the materials requested.
- Stories reprinted may be edited for length, but no other deletions, alterations or other changes may be made without the prior written consent of the American Heart Association.
- Artwork labeled "American Heart Association" may be reprinted, but other artwork may not. For artwork permission questions, contact email@example.com
- Stories reprinted may not be placed adjacent to any advertisement, photo, graphic or other content that could be considered inappropriate by the American Heart Association. For questions about whether content is inappropriate, contact firstname.lastname@example.org.
- Stories may not be displayed in any way that gives the appearance that the American Heart Association endorses (implied or otherwise) or is affiliated with any product, service or company.